Skip to Content

APO LET 2.5 (Letrozole 2.5 mg)

Pill with imprint APO LET 2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Apotex Corp..

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO LET 2.5

Letrozole 2.5 mg APO LET 2.5
Letrozole 2.5 mg APO LET 2.5
Letrozole 2.5 mg APO LET 2.5
Letrozole 2.5 mg APO LET 2.5

Letrozole

Imprint
APO LET 2.5
Strength
2.5 mg
Color
Yellow
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
Inactive Ingredients
hydroxypropyl cellulose (type h), hypromelloses, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 8000, sodium starch glycolate type A potato, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
60505-3255 Apotex Corp.
68084-0803 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.